REDHILL BIOPHARMA LTD. (RDHL) Net margin 2015–2024
REDHILL BIOPHARMA LTD. (RDHL) net profit margin by fiscal year — reported net income divided by reported revenue.
-102.8%FY2024 · since FY2015: -703000.0% → -102.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -102.8% | -469.0 pp |
| FY2023 | 366.2% | +482.2 pp |
| FY2022 | -116.0% | -2.0 pp |
| FY2021 | -114.0% | +4.4 pp |
| FY2020 | -118.4% | +554.1 pp |
| FY2019 | -672.5% | -208.1 pp |
| FY2018 | -464.4% | +672.3 pp |
| FY2017 | -1136.6% | +27942.6 pp |
| FY2016 | -29079.2% | +673920.8 pp |
| FY2015 | -703000.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice